Jiang S - Search Results

1

Systemic Inflammation Response Index (SIRI) Independently Predicts Survival in Advanced Lung Adenocarcinoma Patients Treated with First-Generation EGFR-TKIs.

Jiang S, Wang S, Wang Q, Deng C, Feng Y, Ma F, Ma J, Liu X, Hu C, Hou T. Jiang S, et al. Cancer Manag Res. 2021 Feb 15;13:1315-1322. doi: 10.2147/CMAR.S287897. eCollection 2021. Cancer Manag Res. 2021. PMID: 33633464 Free PMC article.

2

SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.

Feng C, Ma F, Hu C, Ma JA, Wang J, Zhang Y, Wu F, Hou T, Jiang S, Wang Y, Feng Y. Feng C, et al. Among authors: jiang s. Cell Cycle. 2018;17(4):448-458. doi: 10.1080/15384101.2017.1395533. Epub 2018 Feb 8. Cell Cycle. 2018. PMID: 29099271 Free PMC article.

3

Adjuvant therapy for resected EGFR-mutant non-small-cell lung cancer.

Ma JA, Jiang S, Hu C, Xie Y, Hou T. Ma JA, et al. Among authors: jiang s. Lancet Oncol. 2018 Mar;19(3):e125. doi: 10.1016/S1470-2045(18)30074-3. Lancet Oncol. 2018. PMID: 29508750 No abstract available.

4

High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs.

Deng C, Zhang N, Wang Y, Jiang S, Lu M, Huang Y, Ma J, Hu C, Hou T. Deng C, et al. Among authors: jiang s. Medicine (Baltimore). 2019 Aug;98(33):e16875. doi: 10.1097/MD.0000000000016875. Medicine (Baltimore). 2019. PMID: 31415428 Free PMC article.

5

Sp1-induced upregulation of the long noncoding RNA TINCR inhibits cell migration and invasion by regulating miR-107/miR-1286 in lung adenocarcinoma.

Gao YW, Ma F, Xie YC, Ding MG, Luo LH, Jiang S, Rao L, Liu XL. Gao YW, et al. Among authors: jiang s. Am J Transl Res. 2019 Aug 15;11(8):4761-4775. eCollection 2019. Am J Transl Res. 2019. PMID: 31497197 Free PMC article.

6

Decitabine reverses gefitinib resistance in PC9 lung adenocarcinoma cells by demethylation of RASSF1A and GADD45β promoter.

Hou T, Ma J, Hu C, Zou F, Jiang S, Wang Y, Han C, Zhang Y. Hou T, et al. Among authors: jiang s. Int J Clin Exp Pathol. 2019 Nov 1;12(11):4002-4010. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933796 Free PMC article.

7

SKIL facilitates tumorigenesis and immune escape of NSCLC via upregulating TAZ/autophagy axis.

Ma F, Ding MG, Lei YY, Luo LH, Jiang S, Feng YH, Liu XL. Ma F, et al. Among authors: jiang s. Cell Death Dis. 2020 Dec 2;11(12):1028. doi: 10.1038/s41419-020-03200-7. Cell Death Dis. 2020. PMID: 33268765 Free PMC article.

8

Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.

Hou T, Jiang S, Wang Y, Xie Y, Zhang H, Feng Y, Ma F, Ma J, Liu X, Hu C. Hou T, et al. Among authors: jiang s. Front Oncol. 2020 Dec 21;10:608300. doi: 10.3389/fonc.2020.608300. eCollection 2020. Front Oncol. 2020. PMID: 33409155 Free PMC article.

9

Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.

Hou T, Jiang S, Wang Y, Xie Y, Zhang H, Feng Y, Ma F, Ma J, Liu X, Hu C. Hou T, et al. Among authors: jiang s. Front Oncol. 2021 Jun 2;11:705406. doi: 10.3389/fonc.2021.705406. eCollection 2021. Front Oncol. 2021. PMID: 34150669 Free PMC article.

10

Nedaplatin-based chemotherapy or cisplatin-based chemotherapy combined with intensity-modulated radiotherapy achieve similar efficacy for stage II-IVa nasopharyngeal carcinoma patients.

Deng C, Zhang N, Jiang S, Zhang H, Ma J, Zou W, Liu X, Hu C, Hou T. Deng C, et al. Among authors: jiang s. Sci Rep. 2022 Jul 13;12(1):11978. doi: 10.1038/s41598-022-16216-0. Sci Rep. 2022. PMID: 35831424 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,871 results

Search Page

Filters